Skip to main content

The JICF mandate is to facilitate dialogue with the industry on various topics related to medical countermeasures (MCMs). These include identifying and, where feasible, offering recommendations to address issues such as market failures and supply chain dependencies that could limit the production capabilities of relevant medical countermeasures and their raw materials.

The JICF enables HERA to closely monitor the state of critical supply chains, identify vulnerabilities and collaborate with the industry to implement corrective measures.